Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Progression of Relapsing-Remitting Demyelinating Disease Does Not Require Increased TCR Affinity or Epitope Spread.
Schwann cells-axon interaction in myelination.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
Cancer specific risk in multiple sclerosis patients.
Highlights from this issue.
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
[Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
Cortical Thinning Correlates with Cognitive Change in Multiple Sclerosis but not in Neuromyelitis Optica.
MicroRNA-23a promotes myelination in the central nervous system.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Experimental models of neuromyelitis optica.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
[Multiple sclerosis and microRNA].
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[(11)C]Methyl-hydroxyfasudil with Positron Emission Tomography.
Learning to swim, again: Axon regeneration in fish.
Characterization of Compensatory Stepping in People with Multiple Sclerosis.
Inverse Correlation of Expression of miR-140-5p with Progression of Multiple Sclerosis and Differentiation of Encephalitogenic Th1 cells.
Can people with multiple sclerosis actually understand what they read in the Internet age?
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »